Understanding Gene-Disease Validity in Hereditary Cancer Testing
- Amanda Jacquart, MS, LCGC
- December 4, 2024
My favorite thing about my role as a Genomic Science Liaison (GSL) at Ambry is that I get to apply my training in genetic counseling and experience working in an oncology clinic to conversations with healthcare providers about genetic testing and technology, helping them make the most informed decisions for their patients. In this blog, I have …
Read More
Progeny Spotlight: Empowering Families with Health History Insights
- November 21, 2024
Early Detection in Action: Angie’s CARE Story
- October 31, 2024
The Power of Progress: Philip's NF1 Clinical Trial Experience
- Meagan Farmer
- May 22, 2024
We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …
Read More
